Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

/PRNewswire/ -- Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its...

Related Keywords

Brazil ,Beijing ,China ,Austria ,Lanzhou ,Gansu ,Australia ,Canada ,Hong Kong ,New Zealand ,Leobendorf ,Niederörreich ,Vienna ,Wien ,Chinese ,Prnewswire Croma Pharma ,Andreas Prinz ,Croma Pharma Gmb ,Uschi Mayer ,China National Biotech Group ,Filler ,Clinical Research Biotechnology Development ,Lanhzou Biotechnique Development ,Lanzhou Biotechnology Development Co ,International Aesthetic Biotech ,Lanzhou Biotechnique Development ,Volume Plus ,Volume Plus Lidocaine ,Biotechnique Development ,Princess Voluma Plus ,Restylane Perlane Lidocaine ,Midface Volume Deficit ,Midface Contour ,Lanzhou Biotechnology Development ,Record Sheet ,Clinical Trial ,Medical Insights Dermal Fillers Market ,Croma Pharma Gmbh ,Croma Pharma ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,New Products Amp Services ,